FIELD: medicine, hepatology.
SUBSTANCE: at achieving alkaline phosphatase of 580 U and more one should introduce ursodesoxycholic acid at the dosage of 15-20 mg/kg and orlistate at the dosage of 90-100 mg twice or thrice daily for patients with steatohepatitis. According to normalization of clinical and biochemical values of blood analyses it is possible to conclude upon successfulness of therapy performed. The method provides clinic-laboratory remission of the disease.
EFFECT: higher efficiency of therapy.
3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING ABDOMINAL OBESITY | 2012 |
|
RU2506943C1 |
METHOD FOR DIAGNOSING THE CASES OF CHRONIC HEPATITIS | 2003 |
|
RU2255659C1 |
METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE | 2011 |
|
RU2473342C1 |
METHOD OF EARLY RECOGNITION OF CHOLEDOCHOLITHIASIS | 2004 |
|
RU2256922C1 |
METHOD OF TREATING VARIX DILATATION OF ESOPHAGUS IN CASE OF PORTAL HYPERTENSION | 2010 |
|
RU2435591C1 |
METHOD OF DIAGNOSING LIVER AFFECTION IN CASE OF ATHEROGENIC DYSLIPIDEMIA | 2008 |
|
RU2403567C2 |
METHOD FOR PREDICTING THE FLOW OF CHRONIC HEPATITIS C | 2003 |
|
RU2256925C1 |
METHOD FOR DIFFERENTIAL DIAGNOSTICS OF CHRONIC HEPATITIS AND CIRRHOSIS AT HEPATOCEREBRAL DYSTROPHY | 2005 |
|
RU2287165C1 |
METHOD FOR DIFFERENTIAL DIAGNOSTIC OF CHRONIC HEPATITIS AND HEPATIC CIRRHOSIS | 2003 |
|
RU2254577C1 |
METHOD OF TREATING METABOLIC SYNDROME | 2009 |
|
RU2398562C1 |
Authors
Dates
2005-03-27—Published
2003-11-13—Filed